Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vincerx Pharma, Inc. - Common Stock (NQ: VINC )

0.1428 -0.0099 (-6.48%)
Streaming Delayed Price Updated: 1:43 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,284,926
Open 0.1430
Bid (Size) 0.1428 (1)
Ask (Size) 0.1448 (8)
Prev. Close 0.1527
Today's Range 0.1399 - 0.1505
52wk Range 0.1450 - 9.372
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-39.31%
-39.31%
1 Month
-25.86%
-25.86%
3 Month
-64.12%
-64.12%
6 Month
-78.90%
-78.90%
1 Year
-88.93%
-88.93%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, NEUE, VINC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Why Vincerx Pharma (VINC) Stock Is Falling
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
VINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024
Via InvestorPlace
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Crude Oil Down Over 1%; Cognyte Software Shares Plummet
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.